Chiesi Farmaceutici S.p.a.

This phase 3 trial tests whether a daily tablet called florensocatib can reduce the number of lung flare-ups in people with bronchiectasis, a chronic lung condition. About 904 participants aged 12 to 85 will be randomly assigned to receive either the drug or a placebo for up to 7…

This trial is testing whether an experimental drug called CHF10196 changes how the body processes two other medications: dabigatran (a blood thinner) and rosuvastatin (a cholesterol drug). Healthy male volunteers will take these drugs alone and then together with CHF10196, and re…

This study looks at whether pantoprazole, a common heartburn medication, changes how the body processes an experimental drug called CHF10196. Healthy male volunteers receive CHF10196 alone and then again after taking pantoprazole. Researchers measure drug levels in the blood to c…